Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, County Mayo, Ireland
Pharmacotherapeutic group: Other ophthalmologicals
ATC code: S01XA20
Carmellose sodium has no pharmacological effect. Carmellose sodium has a high viscosity resulting in an increased retention time on the eye.
The excipients in Celluvisc were chosen to mimic the electrolyte constitution of tears.
Due to the high molecular weight (approx. 90,000 Daltons) carmellose sodium is unlikely to penetrate the cornea.
There are no preclinical data considered relevant to clinical safety beyond data included in other sections of the SPC.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
